GlassScriptPhysician profile
Scott W Hadfield
NPI 1770836397
$9,850.95
in general payments reported to CMS, 2019-2025
39 companies · $2,154 in 2025
The $2,154 reported for 2025 was more than what 96% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $793 · 2022: $2,023 · 2023: $3,280 · 2024: $1,600 · 2025: $2,154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,449 · Travel and Lodging: $1,075 · Education: $511.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,448.70 |
| Travel and Lodging | $1,074.88 |
| Education | $511.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,219.53 | 2021-2025 | Interstim |
| Astellas Pharma US INC | $1,268.54 | 2021-2025 | Xtandi, Myrbetriq, Veozah |
| Sumitomo Pharma America, INC. | $839.25 | 2023-2025 | Orgovyx, Gemtesa |
| Dendreon Pharmaceuticals LLC | $760.84 | 2021-2024 | Provenge |
| Endo Pharmaceuticals INC. | $642.27 | 2021-2024 | Xiaflex, Aveed |
| Abbvie INC. | $501.93 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $423.01 | 2022-2025 | |
| Janssen Biotech, INC. | $390.26 | 2022-2025 | Erleada, Akeega |
| Pfizer INC. | $314.75 | 2021-2025 | |
| Endo USA, INC. | $287.46 | 2024-2025 | Xiaflex, Aveed |
| Accord Healthcare, INC. | $271.28 | 2023-2025 | |
| Myriad Genetic Laboratories, INC. | $253.40 | 2021-2024 | Myrisk, Prolaris |
| Calyxo, INC. | $244.85 | 2025 | Cvac Aspiration System |
| Myovant Sciences INC. | $201.11 | 2021-2022 | |
| Antares Pharma, INC. | $175.84 | 2021-2023 | Xyosted, Tlando, Nocdurna |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $143.12 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $112.08 | 2024-2025 | Adstiladrin |
| Telix Pharmaceuticals | $79.03 | 2024 | Illuccix |
| Travere Therapeutics, INC. | $77.73 | 2021-2022 | |
| Pharmacosmos Therapeutics INC. | $73.30 | 2024 | Cosela |
| Astrazeneca Pharmaceuticals LP | $66.13 | 2021-2023 | Imfinzi |
| Teleflex LLC | $63.46 | 2021 | |
| Novo Nordisk INC | $47.70 | 2024-2025 | Rivfloza |
| Verity Pharmaceuticals INC. | $46.34 | 2025 | Trelstar, Tlando |
| Coloplast Corp | $42.46 | 2022 | |
| Urogen Pharma, INC. | $42.28 | 2022-2025 | |
| Foundation Medicine, INC. | $35.75 | 2022-2023 | Foundationone Liquid Cdx |
| Axonics, INC. | $28.12 | 2023 | Bulkamid, Axonics |
| Progenics Pharmaceuticals, INC. | $25.00 | 2023 | Pylarify |
| Procept Biorobotics Corporation | $21.74 | 2025 | |
| Innovation Technologies INC | $21.38 | 2025 | Irrisept |
| Kerecis Limited | $20.06 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Welch Allyn | $19.16 | 2021 | |
| Sun Pharmaceutical Industries INC. | $18.78 | 2024 | |
| Tolmar, INC. | $16.85 | 2023 | |
| Laborie Medical Technologies Corp. | $16.07 | 2023 | |
| Blue Earth Diagnostics | $14.66 | 2023 | |
| Boston Scientific Corporation | $13.65 | 2025 | Axonics |
| Nevro Corp. | $11.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Hadfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.